Skip to Main content Skip to Navigation
Master Thesis

Cannabis et cannabinoïdes en thérapeutique : comparaison des législations étrangères et situation en France en 2021

Abstract : Cannabis var -sativa, indica or ruderalis- is an ancestral plant, used since its discovery for its therapeutic virtues. However, for many years, its feature to cause dependence was unfavorable to its use in medicine, which led to its withdrawal from the French pharmacopoeia in 1953 and its inclusion in the Single Convention on Narcotic Drugs of 1961. However, later, thanks to the discovery of the endocannabinoid system and its operation, the medicinal properties of cannabis were once again acknowledged. Scientific research on cannabis and cannabinoids in therapy has been on the rise all over the world for the past ten years. To date, many countries, including in Europe, have already legalized the use of cannabis for medical purposes. In France, decree n° 2013-473 authorizes since 2013 to use pharmaceutical specialties based on cannabinoids in therapy. In 2018, the National Medicines and Health Products Safety Agency was tasked by the government to assess the relevance and feasibility of making medical cannabis available in France. The study of this plant and the different legislation adopted by the pioneer countries is essential to understand what motivated the French decision. France has studied the results of the regulatory provisions already established in these other countries in order to draw inspiration from them and to best adapt the conditions of its own experimentation.
Document type :
Master Thesis
Complete list of metadata

https://dumas.ccsd.cnrs.fr/dumas-03463920
Contributor : UFR Santé UNICAEN Connect in order to contact the contributor
Submitted on : Thursday, December 2, 2021 - 5:33:56 PM
Last modification on : Saturday, December 18, 2021 - 3:53:36 AM
Long-term archiving on: : Thursday, March 3, 2022 - 8:24:33 PM

File

HUET-Alizee.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-03463920, version 1

Citation

Alizée Huet. Cannabis et cannabinoïdes en thérapeutique : comparaison des législations étrangères et situation en France en 2021. Sciences pharmaceutiques. 2021. ⟨dumas-03463920⟩

Share

Metrics

Record views

42

Files downloads

14